Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Francesco Amenta"'
Autor:
Proshanta Roy, Daniele Tomassoni, Seyed Khosrow Tayebati, Ilenia Martinelli, Francesco Amenta
Publikováno v:
Cells
Volume 10
Issue 10
Cells, Vol 10, Iss 2528, p 2528 (2021)
Volume 10
Issue 10
Cells, Vol 10, Iss 2528, p 2528 (2021)
The association between obesity and loss of cognitive performance has been recognized. Although there are data regarding the metabolic alterations in obese conditions and the development of neuroinflammation, no clear evidence concerning obesity-rela
Autor:
Francesco Amenta, Gabriella Marucci, Catia Lambertucci, Michela Buccioni, Diego Dal Ben, Rosaria Volpini
Publikováno v:
Neuropharmacology. 190
Alzheimer's disease (AD), the most common cause of adult-onset dementia is characterized by a progressive decline of cognitive functions accompanied by behavioral manifestations. The main class of drugs currently used for the treatment of AD are acet
Autor:
Francesco Amenta, E. Traini, Vincenzo Bramanti, Daniele Tomassoni, Rosanna Avola, Marcella Renis, Giuseppe Antonio Malfa, D. Bronzi, M. Napoli, S. Grasso
Publikováno v:
Journal of Neuroscience Research. 92:86-94
Lipoic acid plays a crucial role as antioxidant and metabolic component of enzymes involved in glucose metabolism of different cell types. Choline alphoscerate (α-glyceryl-phosphoryl-choline [αGPC]) is a semisynthetic derivative of phosphatidylchol
Autor:
Laura Serafina Cerasa, Daniele Tomassoni, Piera Sozio, Francesco Amenta, Seyed Khosrow Tayebati, Antonio Di Stefano
Publikováno v:
Journal of the Neurological Sciences. 302:49-57
The influence of one week treatment with the choline-containing phospholipids cytidine-5'-diphosphocholine (CDP-choline) and choline alphoscerate (L-alpha-glyceryl-phosphorylcholine) at choline-equivalent doses (CDP-choline: 325 mg/kg/day; choline al
Publikováno v:
Clinical and Experimental Hypertension. 30:732-743
The cholinergic marker vesicular acetylcholine transporter (VAChT) was investigated in different cerebral areas of spontaneously hypertensive rats (SHR) by immunochemistry (Western blot analysis) and by immunohistochemistry. SHR were used as an anima
Autor:
Franco Gatta, Francesco Amenta, Khosrow Tayebati, Anna Borioni, Maria Rosaria Del Giudice, Stefano Pieretti, Paolo Tucci, Carlo Mustazza
Publikováno v:
Archiv der Pharmazie. 336:143-154
A series of 1-methyl-5-(pyrazol-3- and -5-yl- and 1,2,4-triazol-3- and 5-yl)-1,2,3,6-tetrahydropyridine derivatives structurally related to arecoline were synthesized and evaluated on M 1 , M 2 , and M 3 muscarinic receptors using [ 3 H]pirenzepine a
Publikováno v:
Clinical and Experimental Hypertension. 24:697-713
The involvement of an impaired cholinergic neurotransmission in the pathophysiology of cognitive impairment occurring in vascular dementia (VaD), as well as the possibility of treating it by stimulating cholinergic neurotransmission was reviewed. Pre
Autor:
D. Bronzi, Rosanna Avola, Riccardo Ientile, M. Napoli, Francesco Amenta, Daniele Tomassoni, Agatina Campisi, G. Li Volti, S. Grasso, Vincenzo Bramanti
Publikováno v:
Neurochemical research. 37(12)
Heme oxygenase-1 (HO-1) plays a crucial role in oxidative stress processes, apoptosis and cell differentiation. Further, some proteins related to cell cycle including cyclins and p21 are important markers of astrocyte cultures. Aim of investigation w
Publikováno v:
Journal of the neurological sciences. 283(1-2)
The present study was designed to assess if treatment with acetylcholinesterase inhibitor galantamine and the cholinergic precursor choline alphoscerate (alpha-glyceryl-phosphoryl-choline) alone or in association has any protective effect on brain mi
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 26(4)
A decline of cholinergic neurotransmission probably contributes to cognitive dysfunction occurring in Alzheimer's disease (AD) and vascular dementia (VaD). Acetylcholinesterase (AChE)/cholinesterase (ChE) inhibitors are the only drugs authorized for